These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31789011)

  • 41. Adalimumab or infliximab for the prevention or treatment of post-operative recurrence in Crohn's disease.
    Yamamoto T
    J Crohns Colitis; 2013 May; 7(4):e157. PubMed ID: 23021875
    [No Abstract]   [Full Text] [Related]  

  • 42. Preventing acute gout when starting allopurinol therapy. Colchicine or NSAIDS?
    Lewin G
    Med J Aust; 1993 Dec 6-20; 159(11-12):833. PubMed ID: 8264482
    [No Abstract]   [Full Text] [Related]  

  • 43. [Postoperative recurrence: adalimumab is an effective standard medication].
    Hofmann-Aßmus M
    Z Gastroenterol; 2014 Mar; 52(3):260. PubMed ID: 24761446
    [No Abstract]   [Full Text] [Related]  

  • 44. Induction of severe systemic lupus erythematosus by TNF blockade and response to anti-IL-6 strategy.
    Adler S; Kolev M; Varisco PA; Tham M; von Gunten M; Tappeiner C; Villiger PM
    J Allergy Clin Immunol; 2013 Apr; 131(4):1235-7, 1237.e1. PubMed ID: 23154083
    [No Abstract]   [Full Text] [Related]  

  • 45. Ustekinumab therapy for severe interstitial granulomatous dermatitis with arthritis.
    Leloup P; Aubert H; Causse S; Le Goff B; Barbarot S
    JAMA Dermatol; 2013 May; 149(5):626-7. PubMed ID: 23677104
    [No Abstract]   [Full Text] [Related]  

  • 46. [Recurrent pericarditis, colchicine and pericarditic pain without evident disease].
    Betrián Blasco P; del Alcázar Muñoz R
    An Pediatr (Barc); 2006 Sep; 65(3):273-4. PubMed ID: 16956513
    [No Abstract]   [Full Text] [Related]  

  • 47. Identifying Patient Candidates for IL-1 Inhibition: Lessons From Real-World Cases.
    Avram A; Duarte C; Santos MJ; Papagoras C; Ritis K; Scarpioni R; Schmidt WA; Skendros P
    Joint Bone Spine; 2015 Oct; 82 Suppl 1():eS17-29. PubMed ID: 26717798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Canakinumab for the Patient With Difficult-to-Treat Gouty Arthritis: Review of the Clinical Evidence.
    Bardin T
    Joint Bone Spine; 2015 Oct; 82 Suppl 1():eS9-16. PubMed ID: 26717801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of severe systemic lupus erythematosus by TNF blockade and response to an anti-IL-6 strategy: role of IL-17?
    Shin JI
    J Allergy Clin Immunol; 2013 Nov; 132(5):1257. PubMed ID: 24176686
    [No Abstract]   [Full Text] [Related]  

  • 50. [Non-steroidal anti-inflammatory agents].
    Berenbaum F
    Rev Prat; 2003 Mar; 53(5):502-6. PubMed ID: 12722607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of palmoplantar pustulosis with ustekinumab--the importance of interfering with the IL23/Th17 pathway.
    Pinto-Almeida T; Torres T; Sanches M; Selores M
    Eur J Dermatol; 2013; 23(6):916-7. PubMed ID: 24280259
    [No Abstract]   [Full Text] [Related]  

  • 52. Nonsteroidal anti-inflammatory drugs and colchicine to prevent gout flare during early urate-lowering therapy: perspectives on alternative therapies and costs.
    Peterson DM
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):402-4. PubMed ID: 21133751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Response to letter regarding article "Treatment of acute and recurrent pericarditis".
    Lilly LS
    Circulation; 2013 Nov; 128(19):e392. PubMed ID: 24190943
    [No Abstract]   [Full Text] [Related]  

  • 54. Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report.
    Sermet-Gaudelus I; Stoven V; Annereau JP; Witko-Sarsat V; Reinert P; Guyot M; Descamps-Latscha B; Lallemand JY; Lenoir G
    Mediators Inflamm; 1999; 8(1):13-5. PubMed ID: 10704084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Medications against gout].
    Gast LF; Cats A
    Ned Tijdschr Geneeskd; 1988 Oct; 132(40):1827-31. PubMed ID: 3185770
    [No Abstract]   [Full Text] [Related]  

  • 56. Current Therapeutic Approaches for Targeting Inflammation in Depression and Cardiovascular Disease.
    Zuzarte P; Duong A; Figueira ML; Costa-Vitali A; Scola G
    Curr Drug Metab; 2018; 19(8):674-687. PubMed ID: 29512447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Letter by Chhabra and Spodick regarding article, "Treatment of acute and recurrent idiopathic pericarditis".
    Chhabra L; Spodick DH
    Circulation; 2013 Nov; 128(19):e391. PubMed ID: 24190942
    [No Abstract]   [Full Text] [Related]  

  • 58. Old drug, new trick: colchicine for cardiovascular diseases.
    Dudam R; Dekate P
    J R Coll Physicians Edinb; 2020 Mar; 50(1):49-50. PubMed ID: 32539038
    [No Abstract]   [Full Text] [Related]  

  • 59. Colchicine and indomethacin for the treatment of relapsing polychondritis.
    Mark KA; Franks AG
    J Am Acad Dermatol; 2002 Feb; 46(2 Suppl Case Reports):S22-4. PubMed ID: 11807462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crisaborole, Dupilumab, and Sarilumab.
    Hussar DA; Lee YF
    J Am Pharm Assoc (2003); 2017; 57(5):640-643. PubMed ID: 28882252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.